Pharmsville Balance Sheet Health
Financial Health criteria checks 5/6
Pharmsville has a total shareholder equity of ₩64.0B and total debt of ₩2.2B, which brings its debt-to-equity ratio to 3.4%. Its total assets and total liabilities are ₩71.3B and ₩7.3B respectively. Pharmsville's EBIT is ₩1.6B making its interest coverage ratio -2.5. It has cash and short-term investments of ₩39.5B.
Key information
3.4%
Debt to equity ratio
₩2.18b
Debt
| Interest coverage ratio | -2.5x |
| Cash | ₩39.55b |
| Equity | ₩64.02b |
| Total liabilities | ₩7.26b |
| Total assets | ₩71.28b |
Recent financial health updates
Pharmsville (KOSDAQ:318010) Has A Pretty Healthy Balance Sheet
Mar 31
Here's Why Pharmsville (KOSDAQ:318010) Can Manage Its Debt Responsibly
Dec 24Recent updates
Pharmsville's (KOSDAQ:318010) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Mar 28Pharmsville (KOSDAQ:318010) Has A Pretty Healthy Balance Sheet
Mar 31We're Watching These Trends At Pharmsville (KOSDAQ:318010)
Mar 03Pharmsville's (KOSDAQ:318010) Shareholders Are Down 20% On Their Shares
Feb 10
Factors Income Investors Should Consider Before Adding Pharmsville Co., Ltd. (KOSDAQ:318010) To Their Portfolio
Jan 20Here's Why Pharmsville (KOSDAQ:318010) Can Manage Its Debt Responsibly
Dec 24Is Pharmsville Co., Ltd. (KOSDAQ:318010) A High Quality Stock To Own?
Nov 26Financial Position Analysis
Short Term Liabilities: A318010's short term assets (₩43.6B) exceed its short term liabilities (₩5.4B).
Long Term Liabilities: A318010's short term assets (₩43.6B) exceed its long term liabilities (₩1.8B).
Debt to Equity History and Analysis
Debt Level: A318010 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A318010's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A318010's debt is well covered by operating cash flow (213.2%).
Interest Coverage: A318010 earns more interest than it pays, so coverage of interest payments is not a concern.